Meiling Wu

No ORCID on file · 3 papers in corpus · active 2024-2026

Study types

  • article 2
  • review 1

Condition tags

  • endometriosis 3
  • mesh:D004715 2
  • dysmenorrhea 1
  • infertility 1
review 2026
Neutrophil extracellular traps in gynecological disease: pathogenic mechanisms and therapeutic opportunities
Frontiers in medicine ·doi:10.3389/fmed.2026.1710628

Gynecologic disorders, including infections, sterile inflammatory diseases, endocrine abnormalities, and malignancies, share a common signature of dysregulated immunity within a uniquely hormone-responsive reproductive tract. Neutrophil ext…

article 2024
Microfluidics-derived hierarchical microparticles for the delivery of dienogest for localized endometriosis therapy
Acta biomaterialia ·doi:10.1016/j.actbio.2024.02.017

Drug therapy is one of the most important strategies for treating gynecological diseases. Local drug delivery is promising for achieving optimal regional drug exposure, considering the complex anatomy and dynamic environment of the upper ge…

article 2024
Targeting osteopontin alleviates endometriosis and inflammation by inhibiting the RhoA/ROS axis and achieves non-invasive in vitro detection via menstrual blood
Human Reproduction ·doi:10.1093/humrep/deae052

STUDY QUESTION: How does osteopontin (OPN) in endometriosis ectopic stromal cells (EESCs) participate in the pathogenesis of endometriosis and achieve non-invasive detection in vitro? SUMMARY ANSWER: Targeted OPN regulates endometriosis's n…